文献速递消化内镜消化道肿瘤与早癌

3天利那洛肽给药减少聚乙二醇结肠镜检查肠道准备量的效果:多中心、非劣效性、随机对照试验

Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2025-05-27

这项多中心非劣效性随机对照试验将1607例受试者随机分为3组:利那洛肽+3 L聚乙二醇组(A组)、3 L聚乙二醇组(B组)、利那洛肽+2 L聚乙二醇组(C组)。意向性分析显示,C组肠道准备充分率87.58%(95%CI 85.08%-90.62%)非劣效于A组88.79%(95%CI 86.11%-91.46%)和B组83.99%(95%CI 80.88%-87.09%)。A组总体不良反应发生率高于C组(13.64% vs 8.19%,P=0.012)。

要点

  • 3天利那洛肽+2 L聚乙二醇的肠道准备充分率非劣效于3天利那洛肽+3 L聚乙二醇及单用3 L聚乙二醇。
  • A组总体不良反应发生率13.64%高于C组8.19%(P=0.012)。
  • 息肉检出率(P=0.089)、腺瘤检出率(P=0.776)和肠道准备完成率(P=0.052)组间无显著差异。

核心结论

  • 在平均风险人群中,3天利那洛肽联合2 L聚乙二醇的肠道准备充分率非劣效于3天利那洛肽联合3 L聚乙二醇及单用3 L聚乙二醇。

研究设计与样本

  • 多中心、非劣效性、随机对照试验,在16个医疗中心进行。
  • 符合条件受试者随机分为3组:利那洛肽+3 L聚乙二醇组(A组)、3 L聚乙二醇组(B组)、利那洛肽+2 L聚乙二醇组(C组)。
  • 共纳入1607例符合条件受试者,上传1545例结肠镜检查视频。
  • 主要结局为基于波士顿肠道准备量表的肠道准备充分率;安全性基于不良反应发生率评估。

主要发现

  • 意向性分析中,C组肠道准备充分率87.58%(95%CI 85.08%-90.62%)非劣效于A组88.79%(95%CI 86.11%-91.46%)和B组83.99%(95%CI 80.88%-87.09%)。
  • A组总体不良反应发生率高于C组(13.64% vs 8.19%,P=0.012)。
  • 息肉检出率(P=0.089)、腺瘤检出率(P=0.776)和肠道准备完成率(P=0.052)组间无显著差异。

局限性

  • 原文引言指出利那洛肽的剂量和时机仍需要进一步探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Several studies have investigated the role of linaclotide in bowel preparation; however, dosage and timing still warrant further exploration. METHODS: This noninferiority randomized controlled study was performed in 16 medical centers. The eligible subjects were randomly assigned to 3 groups: the Lct + 3 L polyethylene glycol (PEG) group (group A), the 3 L PEG group (group B), or the Lct + 2 L PEG group (group C). The primary outcome was the adequate bowel preparation rate based on the Boston Bowel Preparation Scale. Safety was assessed based on the incidence of adverse reactions. RESULTS: A total of 1,607 eligible subjects were enrolled, and 1,545 colonoscopy videos were uploaded. In the intention-to-treat analysis, the results of the noninferiority test indicated that the adequate bowel preparation rate in group C (87.58%, 95% confidence interval [CI] 85.08%-90.62%) was neither inferior to that of group A (88.79%, 95% CI 86.11%-91.46%) nor group B (83.99%, 95% CI 80.88%-87.09%). The overall incidence of adverse reactions in group A was higher than that in group C (13.64% vs 8.19%, P = 0.012). There were no significant differences in polyp detection rate ( P = 0.089), adenoma detection rate ( P = 0.776), and bowel preparation completion rate ( P = 0.052). DISCUSSION: The adequate bowel preparation rate of the combination of 3-day linaclotide and 2 L PEG was neither inferior to the combination of 3-day linaclotide and 3 L PEG nor 3 L PEG alone in the average-risk population.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Pan P, Chen H, Wang T, et al. Effect of 3-Day Linaclotide Administration to Reduce the Polyethylene Glycol Volume for Colonoscopy Bowel Preparation: A Multicenter, Noninferiority, Randomized Controlled Trial. Am J Gastroenterol. 2025. PMID: 40423516. doi:10.14309/ajg.0000000000003557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。